Skerry, Ciaran M. and Cassidy, Joseph P. and English, Karen
(2009)
A Live Attenuated Bordetella pertussis Candidate Vaccine Does Not
Cause Disseminating Infection in Gamma Interferon Receptor
Knockout Mice.
Clinical and Vaccine immunology, 16 (9).
pp. 1344-1351.
ISSN 1556-679X
Abstract
Bordetella pertussis is the cause of whooping cough and responsible for 300,000 infant deaths per annum.
Current vaccines require 6 months to confer optimal immunity on infants, the population at highest risk.
Recently, an attenuated strain of B. pertussis (BPZE1) has been developed to be used as a low-cost, live,
intranasal, single-dose vaccine for newborns. Preclinical proof of concept has been established; however, it is
necessary to evaluate the safety of BPZE1, especially in immunodeficient models, prior to human clinical trials.
Here, the preclinical safety of BPZE1 was examined in well-characterized murine models. Immunocompetent
and gamma interferon (IFN-y) receptor knockout mice were challenged by aerosol with either virulent B.
pertussis or BPZE1. The two strains colonized the lung at equal levels, but inflammation was associated with
carriage of only virulent bacteria. Virulent bacteria disseminated to the liver of IFN-y receptor-deficient mice,
resulting in atypical pathology. In contrast, attenuated BPZE1 did not disseminate in either immunocompetent
or immunodeficient mice and did not induce atypical pathology. In neonatal challenge models, virulent B.
pertussis infection resulted in significant mortality of both immunodeficient and immunocompetent mice,
whereas no mortality was observed for any neonatal mice challenged with BPZE1. BPZE1 was shown to elicit
strong IFN-y responses in mice, equivalent to those elicited by the virulent streptomycin-resistant B. pertussis
Tohama I derivative BPSM, also inducing immunoglobulin G2a, a process requiring TH1 cytokines in mice.
These data indicate that a live attenuated whooping cough vaccine candidate shows no signs of disseminating
infection in preclinical models but rather evokes an immunological profile associated with optimal protection
against disease.
Item Type: |
Article
|
Keywords: |
Live Attenuated Bordetella pertussis Candidate Vaccine; Disseminating Infection; Gamma Interferon Receptor
Knockout Mice; |
Academic Unit: |
Faculty of Science and Engineering > Biology |
Item ID: |
6835 |
Identification Number: |
https://doi.org/10.1128/CVI.00082-09 |
Depositing User: |
Karen English
|
Date Deposited: |
19 Jan 2016 14:57 |
Journal or Publication Title: |
Clinical and Vaccine immunology |
Publisher: |
American Society for Microbiology |
Refereed: |
Yes |
URI: |
|
Use Licence: |
This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available
here |
Repository Staff Only(login required)
|
Item control page |
Downloads per month over past year
Origin of downloads